Optiver Holding’s bluebird bio BLUE Stock Holding History

Optiver Holding’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-117	Closed	-$571	–	1478
2025 Q1	$571	Buy	+117	New	+$704	﹤0.01%	1300

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Optiver Holding's BLUE Position: Q2 2025 in Review

Optiver Holding sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 117 shares — an estimated $571 sold.

Optiver Holding first reported a position in BLUE in Q1 2025 and held it in 1 quarter. The position peaked at $571 in Q1 2025. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Optiver Holding reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Optiver Holding sold 117 bluebird bio shares in Q2 2025, an estimated $571.
Optiver Holding first reported a position in bluebird bio in Q1 2025 and held it in 1 quarter.
Optiver Holding's bluebird bio position peaked at $571 in Q1 2025.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Optiver Holding's 13F filing for Q2 2025, filed 14 Aug 2025.